R3 Vascular Appoints Josh Smale as its Vice President of Global Clinical and Scientific Affairs
09. Juli 2024 14:25 ET
|
R3 Vascular
R3 Vascular Inc. is pleased to announce the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
09. Mai 2024 12:00 ET
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
Peripheral Arterial Disease (PAD) Therapeutics Global Strategic Research Report 2024
01. März 2024 06:43 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Peripheral Arterial Disease (PAD) Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global...
ZyVersa Therapeutics Announces a Publication in Journal of the American Heart Association Linking NLRP3 Inflammasomes with Calcification in Arteries of Patients with Peripheral Arterial Disease (PAD)
20. Juni 2023 16:07 ET
|
ZyVersa Therapeutics
PAD, characterized by vascular inflammation and associated calcification, affects 8.5 million people in the United States and contributes to more than 50,000 limb amputations annually, yet there are...
Peripheral Vascular Devices Market estimated to surge ahead at a CAGR of 6.6% by the end of 2032 – Persistence Market Research
20. September 2022 10:00 ET
|
Persistence Market Research
New York, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The global peripheral vascular devices market was worth US$ 4.5 Bn in 2021 and t is expected to expand at a high CAGR of 6.6% over the forecast period...
Hyperlipidemia Drugs Market Size, Share, Qualitative Analysis and Industry Growth Factors and is growing at a CAGR of 2.2% by 2029
30. August 2022 06:23 ET
|
Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed...
Holy Name Medical Center First in the Northeast to Offer Magellan(TM) Robotic System
19. November 2015 06:11 ET
|
Holy Name Medical Center
TEANECK, N.J., Nov. 19, 2015 (GLOBE NEWSWIRE) -- Physicians at Holy Name Medical Center are the first in the Northeast to use the Magellan™ Robotic System, which enables them to perform complex,...